Original Research
Published on 30 Oct 2025
Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies
in Vaccines and Molecular Therapeutics
- 429 views